Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts
Novavax (NASDAQ:NVAX) Stock Price Expected to Rise, TD Cowen Analyst Says - Daily Political
Novavax Surpasses Revenue Expectations in Q1, Surges Over 14%, ETPharma
Q1 2026 Novavax Inc Earnings Call Transcript
Novavax (NASDAQ:NVAX) Issues Quarterly Earnings Results
Why Novavax (NVAX) Is Up 17.4% After Q1 2026 Revenue Plunge And Profit Swing To Loss
Novavax Q1 Earnings Call Highlights
Novavax (NASDAQ:NVAX) Price Target Raised to $9.00 at TD Cowen
Novavax (NASDAQ:NVAX) Shares Up 12.9% After Strong Earnings
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
Novavax beats first-quarter revenue estimates on strength in vaccine deals
Is It Time To Reconsider Novavax (NVAX) After A 95% Five Year Share Price Fall
Assessing Novavax (NVAX) Valuation As Licensing Pivot And Key Vaccine Readout Approach
Novavax (NVAX) to Release Earnings on Wednesday
A Look At Novavax (NVAX) Valuation As It Shifts To Licensing And Awaits Combo Vaccine Data
Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?
Novavax to Report First Quarter 2026 Financial Results on Ma
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
1 Cash-Heavy Stock to Target This Week and 2 We Ignore
Why Novavax (NVAX) Is Down 7.0% After Crushing Q4 Revenue And Earnings Forecasts - And What's Next - Simply Wall St News
Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead
FY2028 EPS Estimates for Novavax Cut by Zacks Research
Zacks Research Issues Negative Forecast for Novavax Earnings - Daily Political
Is It Time To Reconsider Novavax (NVAX) After Recent Share Price Weakness?
Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4
Head-To-Head Contrast: Synlogic (NASDAQ:SYBX) versus Novavax (NASDAQ:NVAX)
Assessing Novavax (NVAX) Valuation After Recent Share Price Volatility And Licensing Expectations
Chandrakant Lahariya | Flu-COVID Combo Vaccines: An Idea Whose Time Has Not Yet Arrived
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts
Is It Time To Reassess Novavax (NVAX) After Recent Volatility And Partnership News
Is Novavax (NVAX) Being Pulled Between R&D Ambitions and Activist Demands for Discipline? - Simply Wall St News
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
Latest news
Show moreZelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks
Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets
Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty
